AGM/EGMJun 9, 2026, 05:31 PM
Bluejay Diagnostics Stockholders Approve Reverse Split, Increase Stock Plan Shares
AI Summary
Bluejay Diagnostics, Inc. held its 2026 annual meeting, where stockholders approved several key proposals. These included the re-election of five directors and the ratification of Wolf & Company, P.C. as the independent auditor. Significantly, stockholders approved an amendment to the 2021 Stock Plan, increasing the shares reserved for issuance by 600,000 to a total of 600,061. Additionally, a proposal for a reverse stock split, with a ratio between 1-for-2 and 1-for-20, was approved, granting the Board discretion to implement it within the next year to maintain Nasdaq compliance, though there is no present intention to do so.
Key Highlights
- Stockholders re-elected Donald Chase, Neil Dey, Svetlana Dey, Douglas Wurth, and Fred Zeidman as directors.
- Approved an amendment to the 2021 Stock Plan, increasing shares available for issuance by 600,000 to 600,061.
- Approved a reverse stock split proposal (1-for-2 to 1-for-20 ratio) for future Nasdaq compliance.
- The Board has discretion to implement the reverse split within 12 months, but no present intention.
- Ratified Wolf & Company, P.C. as the independent registered public accounting firm for 2026.
- Reverse stock split proposal passed with 262,891 votes For vs. 150,322 Against.
- Stock plan amendment passed with 135,750 votes For vs. 94,058 Against.
Price Impact
More from BJDX